ARCHIVES

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

This article is from The Cancer Letter archive.

Vol. 39 No. 19 | May 10, 2013

Download PDF Visit The Full Archive

Related Articles

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

April 27, 2007

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

November 28, 2008

Thomas Tomasi Named New Director Of Roswell Park

June 27, 1986

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

In Brief: Cooper Resigns From DPC Board, Bettinghaus Names, Chairman; William Dewyus Leaves NCI

September 13, 1985